Myasthaenia Gravis
·MeSH: Stiff-Person Syndrome
Prevalence
5.0 / 100K
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
Frequently asked questions
How many drugs are in development for Myasthaenia Gravis?
BioSniper tracks 1 drug in development for Myasthaenia Gravis across 1 company.
How many clinical trials target Myasthaenia Gravis?
There are 2 clinical trials targeting Myasthaenia Gravis tracked by BioSniper.
What is the prevalence of Myasthaenia Gravis?
The estimated prevalence of Myasthaenia Gravis is approximately 5.0 per 100,000 population.
Deep-dive into Myasthaenia Gravis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis